−239 KRW
−33.03 B KRW
88.46 B KRW
104.44 M
About EONE DIAGNOMICS GENOME CENTER CO., LTD.
Sector
Industry
Headquarters
Inchon
Website
Founded
2013
ISIN
KR7245620000
FIGI
BBG00KXPKGJ5
EONE DIAGNOMICS GENOME CENTER Co., Ltd. engages in the operation as a genomics company providing a range of clinical and consumer genetic services. The firm is equipped with cutting-edge genomics data analysis expertise. Its services include non-invasive prenatal diagnostic test, newborn genetic screening test, ophthalmology genetic test, and Direct-to-Consumer genetic test. The company was founded on May 6, 2013 and is headquartered in Incheon, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 245620 is 415 KRW — it has decreased by −5.25% in the past 24 hours. Watch EONE DIAGNOMICS GENOME CENTER CO., LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange EONE DIAGNOMICS GENOME CENTER CO., LTD. stocks are traded under the ticker 245620.
245620 reached its all-time high on Mar 31, 2020 with the price of 10,959 KRW, and its all-time low was 349 KRW and was reached on Jan 25, 2024. View more price dynamics on 245620 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
245620 stock is 9.23% volatile and has beta coefficient of 1.79. Track EONE DIAGNOMICS GENOME CENTER CO., LTD. stock price on the chart and check out the list of the most volatile stocks — is EONE DIAGNOMICS GENOME CENTER CO., LTD. there?
Yes, you can track EONE DIAGNOMICS GENOME CENTER CO., LTD. financials in yearly and quarterly reports right on TradingView.
245620 net income for the last quarter is −3.46 B KRW, while the quarter before that showed −2.28 B KRW of net income which accounts for −52.23% change. Track more EONE DIAGNOMICS GENOME CENTER CO., LTD. financial stats to get the full picture.
No, 245620 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 27, 2024, the company has 112.00 employees. See our rating of the largest employees — is EONE DIAGNOMICS GENOME CENTER CO., LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EONE DIAGNOMICS GENOME CENTER CO., LTD. EBITDA is −5.61 B KRW, and current EBITDA margin is −3.95%. See more stats in EONE DIAGNOMICS GENOME CENTER CO., LTD. financial statements.
Like other stocks, 245620 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EONE DIAGNOMICS GENOME CENTER CO., LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EONE DIAGNOMICS GENOME CENTER CO., LTD. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EONE DIAGNOMICS GENOME CENTER CO., LTD. stock shows the sell signal. See more of EONE DIAGNOMICS GENOME CENTER CO., LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.